Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,500.30 -126.97 -0.81%
Hang Seng 22,939.10 -321.98 -1.38%
S&P/ASX 200 5,077.20 -88.17 -1.71%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

CRY:US

6.3100 USD 0.1800 2.77%

As of 20:04:03 ET on 05/22/2013.

Company Profile for CryoLife Inc (CRY)

CryoLife, Inc. cryopreserves viable human tissues for cardiovascular, vascular, and orthopedic transplant applications. The Company develops and commercializes additional implantable products and single-use medical devices. CryoLife develops bioprosthetic cardiovascular devices, including novel design stentless porcine heart valves marketed in Europe.

Contact Information

CryoLife Inc

1655 Roberts Boulevard NW
Kennesaw, GA 30144
United States
Phone: 1-770-419-3355
Fax: 1-770-426-0031

Key Executives for CryoLife Inc (CRY)

Steven G AndersonChairman/President/CEODavid Ashley LeeExec VP/CFO/COO
David P LangSenior VP:Intl Sales & MktgJeffrey W BurrisVP/General Counsel
Bruce G AndersonVP:US Sales & MktgScott B CappsVP:Clinical Research
David C GaleVP:Research & DevelopmentDavid M FronkVP:Regulatory Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil